What is Neurofibrosarcomas?

Also called a malignant tumor of the peripheral nerve sheath, neurofibrosarcoma is a low-incidence cancer disease that appears in the lining of the nerves that go from the spinal cord to various areas of the body.

Although neurofibrosarcomas can appear in any area of the body, they are more frequent in:

Chest.
Arms.
Legs.

The cause of its appearance is unknown to date, but it is known that the development mechanism is when abnormal cells begin to multiply uncontrollably, accumulating and forming tumors.

Also, there are some potential risks to developing it such as:

Previous radiation therapy sessions.
Having suffered benign nerve tumors.
Having neurofibromatosis 1.

Signs and symptoms Neurofibrosarcomas

Soreness in the affected area.
Inflammation.
Lack of strength in the affected area.
Subcutaneous bulge that grows progressively.
Edema.
Numbness of the affected limb.
Tingling.
Dizziness.
Imbalance.

Diagnosis and treatment Neurofibrosarcomas

The doctor will analyze your symptoms and medical history before performing a physical examination in search of signs of cancer, as well as a neurological examination.

Subsequently, they will request various tests to rule out other conditions and confirm the diagnosis, such as:

X-rays.
MRI.
Computed tomography.
Positron emission tomography.
Tissue biopsy.

The treatment to be followed will depend on the size, location, and stage of the cancer, but generally includes:
Surgical removal of the tumor or in severe cases, amputation of the affected limb.

Radiation therapy.
Chemotherapy.
Physical therapy and rehabilitation.

Since its inauguration in 2009, our Cancer Center has offered chemotherapy and radiation therapy treatments at the level of the best medical centers in the world through a comprehensive care model for cancer patients.

Related centers and departments

ABC Cancer Center
High Specialty Surgery Center
Radiology and Molecular Imaging
Clinical Laboratory

Fuentes:

cancer.org
cancer.net
cancer.gov
cun.es
rarediseases.org
topdoctors.es
mayoclinic.org
medlineplus.gov
medigraphic.com
Baena-Ocampo LC, Reyes-Sánchez A, Alpízar-Aguirre A, et al. Tumor de vaina nerviosa periférica maligno asociado a neurofibromatosis tipo 1. Informe de dos casos. Cir Cir. 2009;77(5):391-395.

How can we help you?

The dissemination of the content of this material is for informational purposes only and does not replace, under any circumstance or condition, a consultation with a specialist doctor, for which the ABC Medical Center is not responsible for the different use that may be given to it. If you require more information related to the subject, we suggest you contact the specialist doctor you trust directly.

Index

Content

Get from 3 to 9 interest-free installments* with American Express or 6 installments* when paying with Citibanamex, BBVA, HSBC, Santander or 12 installments*
when paying with Citibanamex.

Comparison of COVID-19 vaccines

Pfizer-
BioNTech

Pfizer-BioNTech

What is its effectiveness and what does it refer to?

Vaccine type: mRNA
Effectiveness: 95% after the second dose in the prevention of symptomatic COVID-19.

No Does not contain egg, latex, or preservatives.

How many doses are needed?
Two doses are needed, at least 21 days apart (or up to six weeks apart, if necessary).

Who should or shouldn’t get the vaccine?
People who should receive the vaccine are those over 16 years old.
People who should not receive the vaccine are those who have a history of anaphylactic shock (severe allergy) or who are allergic to any component of this vaccine such as polyethylene glycol (PEG) or polysorbate.

What are the possible side effects of the vaccine?
Pain where the injection was given, fatigue, headache, muscle pain, chills, joint pain, fever, nausea, malaise, and swollen lymph nodes.

How long will it take for me to be protected and what does it protect me from?
After 14 days of having the complete scheme (after the administration of the 2nd dose), the protection period is still under study. It protects us from serious COVID-19 or requiring hospitalization.

Moderna

What is its effectiveness and what does it refer to?

Vaccine type: mRNA
Effectiveness: 94.5% after the second dose in the prevention of symptomatic COVID-19.

Does not contain egg, latex, or preservatives.

How many doses are needed?
Two doses are needed, at least 28 days apart (or up to six weeks apart, if necessary).

Who should or shouldn’t get the vaccine?
People who should receive the vaccine are those over 18 years old.
People who should not receive the vaccine are those who have a history of anaphylactic shock (severe allergy) or who are allergic to any component of this vaccine.

What are the possible side effects of the vaccine?
Pain where the injection was given, fatigue, headache, muscle pain, chills, joint pain, fever, nausea, and swollen lymph nodes in the arm in which you received the injection.

Janssen/
Johnson
& Johnson

Janssen/ Johnson & Johnson

What is its effectiveness and what does it refer to?

Vector-based vaccine.
Effectiveness: 72.0% in the prevention of symptomatic COVID-19.
85% in the prevention of severe COVID-19.

Does not contain egg, latex, or preservatives./strong>

How many doses are needed?
Only one dose in needed.

What are the possible side effects of the vaccine?
Pain where the injection was given, headache, fatigue, muscle pain, chills, fever, and nausea.

How long will it take for me to be protected and what does it protect me from?
After 28 days of having the complete scheme (the last dose applied), the protection period is still under study. It protects us from 85% serious COVID-19 or requiring hospitalization.

AstraZeneca
and
Oxford
University

AstraZeneca and Oxford University

What is its effectiveness and what does it refer to?

Adenovirus vector-based vaccine.
Effectiveness: 82% after the second dose in the prevention of symptomatic COVID-19.

How many doses are needed?
Two doses are needed, at least 56 days apart (or up to 84 days apart, if necessary).

What are the possible side effects of the vaccine?
Pain where the injection was given, fatigue, headache, myalgia, arthralgia, and fever, which were mild to moderate in intensity and disappeared within 48 hours of vaccination.

Sputnik V

What is its effectiveness and what does it refer to?

Adenovirus vector-based vaccine.
Effectiveness: 92% after the second dose in the prevention of symptomatic COVID-19.

How many doses are needed?
Two doses are needed, at least 21 days apart (or up to six weeks apart, if necessary).

What is Neurofibrosarcomas?

Signs and symptoms Neurofibrosarcomas

Diagnosis and treatment Neurofibrosarcomas

Related centers and departments

Fuentes:

Index

Specialist in Neurofibrosarcomas